)
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Anjali Singh covers the automobile and pharmaceutical sectors, focusing on trends, policy developments, regulatory changes, industry expectations, corporate results among others. A postgraduate in communication journalism, she has a strong inclination towards data-driven reporting and enjoys breaking down complex topics to make them interesting and relevant for readers.
Shingles, caused by the reactivation of the varicella-zoster virus-the same virus responsible for chickenpox-is a painful disease that can lead to severe and long-lasting complications
Company's expansion move is linked to its decision to acquire Camso, a global leader in OHT solutions
A key component of the transactions includes a $650 million funding arrangement for its U.S. subsidiary, Sun Pharmaceutical Industries Inc. (SPI Inc.), to support business expansion
Credit rating agency ICRA forecasts that this growth will be driven by strong export performance, increasing localisation of electric vehicle (EV) components, and rising demand in the aftermarket
This move aligns with the company's aggressive domestic expansion, where it plans to double its centres across India from the current 50 to 100, backed by an investment of Rs 500 crore
In a recent discussion, the company confirmed that while supply chain disruptions previously affected availability, the situation has now stabilised
MaxiVision is also setting its sights on the stock market, with plans to go public within the next two years
Already charger utilisation levels have increased in India with the growing population of EVs
This acquisition marks a significant step in Jubilant Biosys' global strategy, providing a foothold in Europe's expanding pharmaceutical and biotech ecosystem
The patient, who was a resident of the Wadala area, was admitted to BMC-run Nair Hospital on January 23, 2025, after experiencing weakness in his legs
Bengaluru-based EV startup says its product is India's longest-range electric scooter
Overall hospital occupancy rose to 68 per cent from 66 per cent last year, driven by increased patient volume
Between April and September 2024-25, major players reported an almost 25-40 per cent decline in medical tourist flow from Bangladesh
Indian biosimilar exports, presently valued at $0.8 billion, are expected to grow fivefold to $4.2 billion by 2030 and reach $30-35 billion by 2047
The company said that on a standalone basis, it reported its highest-ever revenue for the first nine months of the financial year, reaching Rs 30,818 crore, up 10 per cent
The company has invested $15 million to localise the 2.8L F28 engine, which was developed in Europe, to reduce import dependence and improve cost efficiency
Sequentially, the revenue from operations fell by 1.9 per cent, with net profit also falling by 20.9 per cent
Deliveries for the Roadster series are set to begin in mid-March. The company has been teasing the launch of its electric motorcycles multiple times
The company's India business, comprising both formulations and consumer wellness divisions, contributed 38 per cent of consolidated revenue
On a sequential basis, the company's revenue declined by 7.7 per cent, while PAT also fell by 32.5 per cent